Three ileus cases associated with the use of dipeptidyl peptidase‐4 inhibitors in diabetic patients

Three ileus cases associated with the use of dipeptidyl peptidase‐4 inhibitors in diabetic patients

Dipeptidyl peptidase (DPP)‐4 inhibitors are a new class of antidiabetic drugs that increase incretin hormone levels to enhance blood sugar level‐dependent insulinotropic effects, suppress glucagon action, and reduce bowel motility. These incretin effects are ideal for blood sugar control. However, t...

Full description

Bibliographic Details
Main Authors: Kanasaki, Keizo, Konishi, Kazunori, Hayashi, Ranji, Shiroeda, Hisakazu, Nomura, Tomoe, Nakagawa, Atsushi, Nagai, Takako, Takeda‐Watanabe, Ai, Ito, Hiroki, Tsuda, Shin‐ichi, Kitada, Munehiro, Fujii, Mizue, Kanasaki, Megumi, Nishizawa, Makoto, Nakano, Yasuharu, Tomita, Yasuto, Ueda, Nobuhiko, Kosaka, Takeo, Koya, Daisuke
Format: Online
Language:English
Published: Wiley-Blackwell 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020265/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020265/

Similar Items